client-specif headwind perhap kitchen-sink crater
outlook downgrad perform
oper disrupt long-term outlook/
justifi multipl high-qual earn
cell therapi a-team aim outdo initi outperform
color fundament focu call
updat flat tibsovo sale highlight need label
zynteglo prep maiden commerci flight
gutsi protocol amend ecospor
moment truth inch forward week look
book impact lack decis urgenc sale
analyst certif import disclosur see
record book help new veradigm segment
review focu new ceo busi keep improv
headway in-vivo edit
report wait ration market
continu make progress product gain traction
netcentr growth margin
report result intern shine
go-to-market continu
look great
role-bas offer reson custom
keep go go
upsid surpris result rais price target
caffein start maintain perform
quick read signal recruit stabil ww
dlph lay foundat improv profit
result expect maintain perform
soft start year guidanc maintain
substanti outperform maintain
yield portfolio bit lower qoq dividend intact
great busi model fundament trend easi
solid quarter continu impress fre growth
client-specif headwind perhap kitchen-sink crater outlook downgrad perform
cogniz report soft result revenu grew y/i cc vs our/street estim oper profit
miss our/street expect drive adjust ep versu our/street expect new ceo five
week reflecting-cli specif headwind bank healthcar slash recent provid februari revenu outlook
ep outlook mid-point suspect conservat room invest built lower margin
expect also long-term financi object provid novemb appear suspect given uncertainti regard revenu
trajectori profit trend step sidelin accordingli downgrad perform remov pt
driver behind januari upgrad intact invest stori improv discount valuat
traffic out-performance vs peer could soon captur market attent new averag check improv drive healthier compstore trend
analysi also suggest street earn estim set conserv attract risk/reward
analyst day fall could highlight new growth strategi could provid boost model l-t growth algorithm stock valuat
oper disrupt long-term outlook/upsid larg unchang
report adj ep our/consensu in-lin core growth off-set weaker
anticip margin perform due unfavor mix ineffici relat wc optim importantli core order increas
y/i vs challeng comp robust us em demand trend support guid full-year core sale growth
miss stronger usd pressur ep guidanc vs relat headwind temporari remain
confid defens core growth prospect leverag smart-tech adopt multi-year om runway result mid-teen core
ep compound-annual-growth-rate ad strateg capac rebuild believ remain posit intermediate-term earnings/cash flow
justifi multipl high-qual earn dividend increas
high-qual earn beat along low capital-expenditure spend eas concern rampant spend drove short-term
under-perform earn sinc versu xop oil production/pr strong unit expens profil drove earn
beat total capital-expenditure may rais eyebrow one-tim exploratori acquisit consist compani
comment would explor focu strong result combin surprisingli bold dividend increas
drive rel out-performance friday tailwind friday affirm plan well cost reduct track
news increas oil export capac mb/d mb/d
cell therapi a-team aim outdo initi outperform
immedi aftermath kite pharma sale gilead kite core leadership reassembl take fundament limit
today car-t therapi rather rest laurel recent success allogen aim make product includ yescarta
kymriah obsolet name compani develop allogen donor-deriv product could address signific issu
surround today autolog patient-deriv car-t includ manufactur bandwidth cost consist allogen combin industry-
lead experi car-t clinic trial manufactur logist could collect translat rapid develop timelin
wherewith make off-the-shelf car-t commerci realiti multipl de-risk data readout expect next month
initi outperform pt
driven solid growth across busi unit strong margin improv equip robust contribut acg adjust
ebitda beat our/street estim revenu also our/street forecast order activ
remain strong barg order log reach book-to-bil vs end strong solid outlook
manag reiter guidanc call revenu adjust ebitda maintain outperform
color fundament focu call
updat flat tibsovo sale highlight need label expans
thursday agio report result review recent progress view rel flat tibsovo sale underscor need
label expans agio execut ambiti develop strategi broaden tibsovo label beyond r/r aml see multipl label
expans opportun horizon newly-diagnos aml patient solid tumor notabl tibsovo combin
azacitdin recent receiv breakthrough therapi design front-lin aml could potenti acceler label expans
larg segment elderli patient anticip sever upcom readout time-frame could derisk compani
inhibitor aml cholangiocarcinoma glioma howev given low preval mutat aml remain
zynteglo prep maiden commerci flight
thursday bluebird announc earn provid busi updat posit chmp opinion hand believ lentiglobin
trade name zynteglo track approv transfusion-depend thalassemia tdt europ given bluebird plan
stage roll-out begin germani believ investor maintain temper expect sale detail price
reimburs could announc follow regulatori approv compani schedul analyst event may eha
anticip increment clinic updat on-going lentiglobin trial sickl cell anemia sca well tdt updat
car-t result includ top-lin result pivot karmma trial could serv major catalyst stock reiter perform
gutsi protocol amend ecospor
thursday sere report result review recent progress take decis action face sluggish enrol manag
announc decis re-siz on-going ecospor trial recurr difficil infect cdi overal trial size
cut nearli half manag anticip enrol could complet year-end top-line data expect earli despit
structur chang ecospor believ posit result could still support acceler approv given breakthrough
therapi design separ manag reiter commit deliv clinic result on-going trial investig
ulcer coliti uc melanoma investor could reward data-rich despit near-term financ
moment truth inch forward week look potenti resvax updat
report financi result provid import oper updat includ disclosur plan meet fda
four european regul discuss potenti resvax file despit phase miss primari endpoint issuanc
common stock atm program last two week march bring total optim relationship
gate foundat resvax extend hope provid regulatori updat earlier prior estim
base case assum fda seek addit studi resvax prior approv product approv eu anoth
jurisdict allow distribut product develop market
book impact lack decis urgenc sale elong
book quarter y/i system sale y/i lack urgenc small hospit decis make
elong sale cycl manag underscor growth sale pipelin express confid win rate time
deal closur remain uncertain uncertainti could impact number growth year compani ahead plan
cost save effort note complet save plan addit manag note identifi put action plan save
anoth cost help profit sale hiccup impact revenu growth
record book help new veradigm segment
report record book help strength new veradigm segment management highlight veradigm
rel contribut much higher current revenu contribut quarter compani expect continu pursu
opportun segment expand footprint tradit provider-fac solut continu believ market current
sluggish appetit spend like continu impact growth traction paragon segment attrit seem revers
opportun side bring hope major chang estim wait segment detail
post revenu beat consensu estim includ inbrija sale line
estim focus inbrija launch trajectori highlight rx request receiv april physician
wrote request estim inbrija sale vs consensu guid comparison three parkinson
therapi launch expect ema final decis inbrija year-end seek potenti ex-u commerci partner reiter
peak sale goal plan becom cf-posit without addit fund also provid platform updat
acut migrain grow adopt inbrija support launch maintain perform detail full
provid busi updat along result address sever area interest includ launch plan zulresso iv
brexanolon portfolio priorit process optim pipelin invest encourag portfolio approach
well fund cash end face multipl new indic new molecul select attract
invest opportun includ new indic result archway studi bipolar depress expect
juli nmda receptor modul offer potenti cognit benefit variou disord next-gener
gaba receptor modul neurolog condit anoth studi requr eu approv zulresso maintain outperform
detail report
review focu new ceo busi keep improv
gilead report sales/earn provid investor updat focu new ceo depart
cfo note busi notic strengthen first-ev quarter year record y/i growth three lead
commerci franchis hiv hcv cell therapi notch strong quarter adjust oper margin slightli larg
due increas spend cell therapi ex-u launch howev invest provid leverag time consider time
spent tri gaug new ceo appetit bd/m bolster pipelin asid strong support filgotinib program
mr day defer granular feedback pend dilig adjust number stay bullish
headway in-vivo edit
report result collabor revenu opex ep vs consensu ep cash balanc
manag estim fund oper call includ sever updat pipelin in-vivo edit
ex-vivo engin t-cell remain track nda submiss attr prepar manufactur
 toxicolog on-going data present asgct first demonstr target insert liver non-
human primat view valid modular lnp aav approach in-vivo edit asgct present engin
cell therapi insert isol t-cell show progress cell therapi
report wait ration market
ci report ep top street consensu adjust result exclud gain transit
client invest off-set amort integration/transact cost beat driven strong result
integr medic vs opco slightli off-set group soft vs opco meanwhil new
segment move part line manag estim due organ sale growth follow
quarter rais ep guidanc result rais ep estim
report solid result in-lin revenu y/i better expect ep cfo bill y/i metric
revenu guidanc notch mid-point bill guidanc saw similar trend vs prior
mid point wherea emea grew y/i vs america saw temporari soft y/i vs
driven partli hire target slightli plan lose sleep believ overal trend remain strong
foot driven product refresh well secur fabric realiz solid traction custom partner
estim remain larg intact outperform/pt
continu make progress product gain traction transit headwind remain
non-gaap basi post eps/revenu vs consensu estim note
see good custom activ well strong demand teradata vantag platform encouragingli recur revenu increas
constant currenc compani highlight fact sizabl subscript transact america slip
addit note robust deal pipelin give manag confid abil achiev guidanc
on-going shift subscript model time intern invest remain key variabl impact trajectori
maintain perform rate
report solid result rais guidanc organ revenu ex macro/acquisit increas y/i ep
vs our/street estim encouragingli shell convers complet apr ramp schedul
complet reach full run-rat annual revenu combin rais guid
anticip revenu adj ep vs prior guid growth remain broad-based across segment
includ acquisit benefit quarter remain optimist regard near- intermediate-term growth lever
maintain outperform rais pt
cloud
follow-up solid quarter manag optimist netcentr growth margin
grew revenu in-lin normal fx traffic growth y/i increas new ott offer come
market custom roll exisit direct connect contract along averag price per mb stabil believ netcentr
busi inflect toward posit sequenti growth next quarter trend posit invest sale team
ad full-tim quota-bear repres rep ad sinc addit weigh rep product fell
close orders/rep last quarter rebound new rep matur despit margin expand bp per year
cog ahead schedul stock trade dividend yield
attend build develop confer next week seattl critic event need convinc develop
adopt ecosystem github azur power platform discuss head confer note week
earn recap solid volum internet cloud
model updat due account chang
report result intern shine go-to-market continu
report good result rais guidanc highlight includ strong intern sale perform includ record emea
win good strateg product attach rate non-sap revenu growth acceler balanc bill underwhelm
owe soft new custom win slow domest growth deceler sap channel contribut suggest core go-to-market
strategi still ramp rais estim risk moreov manag allud potenti increas competit categori
could caus sale cycl elong bottom line believ qualiti busi visionari manag team disrupt
larg account autom opportun howev remain sidelin data point go-to-market strategi
work maintain perform
report result growth acceler setup look great
report good result assess posit believ busi success execut go-to-market strategi
sale capac market event etc result increas pipelin momentum visibl path growth later year
balanc manag re-affirmed full-year revenu guidanc despit beat may take time investor gain comfort
bottom line believ well posit capit shift consum engag behavior mobil messag channel
setup good busi display improv fundament acceler growth help catalyz re-
rate valuat multipl higher toward saa industri averag reiter outperform pt
lower pt expect investor skeptic seo headwind key driver vrbo formerli homeaway
book deceler vs check prior confer discuss larger properti manag follow report
indic competitor gain share vrbo key market said encourag core-ota night acceler normal
better ebitda street moder opex conduc margin expans expect share range-
bound investor wrap head around proper pace vrbo growth howev local initi materi asset-sc
global accommod trend offer favor risk/reward ebitda maintain outperform
analyt collabor infrastructur softwar
arista report in-lin quarter top-lin guidanc well consensu view reflect paus spend
digest signific invest see share remain range-bound arista offer insight cloud demand trend
part thesi play illustr strong enterpris traction posit campu commentari near-term road
may bumpi expect campu ramp follow earli expect updat clarifi near-
term cloud trend arista june analyst day support solidifi new share repurchas program remain buyer adjust
estim results/guid pt remain maintain outperform
analyt collabor infrastructur softwar
role-bas offer reson custom
tableau report solid though sale slightli miss expect strong subscript adoption/mix vs qoq impact
licens revenue growth due lower up-front revenue near end subscription-driven revenue volatil manag bullish
growth better reflect strong custom demand check larg consist manag view suggest continu strong
business-lin user demand modern tool excel leverag tableau role-bas offer creater/explorer/view
execut bar remain high believ tableau sustain current moment given sale investment/platform expans tableau prep
conductor ask data end-to-end analyt etc maintain perform adjust estim reflect updat results/guid continu
believ tableau reach higher end target
keep go go
report result thursday sales/ep match consensu outlook edg
street notabl mp top-line y/i larger hpa peer expect y/i gm
y/i expect flat q/q management expect top-line growth continu outpac peer mp myriad
greenfield opportun auto industri server ramp channel inventori day q/q day intern
expect inventori remain elev year current correct conclud visibl improv spite macro uncertainti mp
remain pois sustain outsiz growth/upsid top structur growth/gm stori remain long-term buyer
skywork report earn thursday sales/ep top consensu june outlook
line despit handset industri headwind smartphon market expect led china set
tough year compon supplier broad market busi continu perform well remain track growth
management highlight secur massiv mimo infrastructur win nokia ericsson huawei suppli high power amp
antenna switch ramp in-hous baw product volum heavi exposur declin smartphon market
set tough year growth despit consist top-notch management execut upsid catalyst appear limit year risk/reward
balanc maintain perform
mediatek gross margin rebound digitim
cloud server datacent see signific shipment digitim
qcomm book deal ee time
emerg technolog servic
upsid surpris result rais price target
report revenue/ep compar consensu manag rais
revenu guidanc vs street new mid-point guidanc indic growth
upsid surpris came mostli south korea custom q/q sale chines panel maker also grew significantli
account total year ago chines panel maker start prove abil ship display high volum
believ see signific expans market across display size reiter outperform rate rais
price target
emerg technolog servic
report in-line-to-bett march quarter call spent reiter strategi fewer higher-qu titl regular content
updat deeper engag leverag platform mean mobil content busi model howev take
time correspond theme first sign new strategi like come soon launch next call duti howev
updat blizzard like novemb mobil remain quarter away meantim monthli activ activis
blizzard guidanc feel bit lacklust continu believ strateg pivot right one sit sidelin
wait event unfold
caffein start maintain perform
dnkn highlight solid dunkin compstore best quarterli comp four year driven averag check gain quarter
profit growth track ahead full-year outlook management kept guidanc unchang comparison toughen time
could prove lumpi consensu alreadi sit outlook upper-end expect littl chang street estim initi perform thesi
launch coverag march predic street alreadi appreci dnkn healthi financi target could becom
construct valuation-l pullback
quick read signal recruit stabil ww
yesterday may market close ww report result share ww under-perform meaning late
indic weaker plan new member recruit earli close review result comment manag
suggest clearli subscrib growth remain soft trend later period stabil track better subdu guidanc ww
mean wood said encourag new market part compani reson core custom
help leverag increasingli well built-out digit infrastructur continu monitor ww close
report adj ep vs our/consensu top-lin miss vs estim influenc poc
account revis off-set margin out-performance adj om vs estim partli benefit poc-driven
mix shift quarter highlight book highest level three year fourth consecut quarter
adj gross oper margin expans
given sale order perform latter reflect gener improv demand maintain sale guidanc y/i
ex-fx divestitur adj ep guidanc also maintain beat on-going transform benefits/margin
progress suggest realist upsid rang
report adj ep vs our/consensu beat driven stronger anticip america perform
revenu margin organ sale increas y/i slightli expect oper margin came
model exhibit intra-day report releas
america core sale increas y/i broad-based growth across plumb heat hot water dd drain water qualiti
product om expand y/i volum price product off-set inflat invest headwind
europ core sale increas y/i driven continu strength drain one addit ship day adj om expand y/i
volum price product partli off-set inflat mix invest
gross margin continu eke expans y-o-i second straight quarter third sequenti result tallest
sinc look continu midpoint revenu guidanc compar look bit
challeng consid april lsd march jan /feb lsd also key bridg item equal workday elimin
drag impact sl add organ sale improv elimin effect workday obvious fx/acquisit
may/jun y-o-i comparison littl easier slightli higher two-year stack larg util contract estim sale
five year commenc bill margin gm improv broadli
sustain growth resourc optim
dlph lay foundat improv profit
share flattish thursday dlph beat adj ep consensu indic bia high end ep guidanc
intern factor drive margin improv look larg structur could prove estim
expans conserv ceo dauch post-orient assess oper suggest meaning addit lever pull
next sever year could improv profit multipl busi line custom book mix transit view provid
de-risk futur growth reiter confid pe revenue/margin trajectori posit rais
estim maintain outperform rate
production/pr pre-announc anticip surpris earn got slight miss us/consensu deriv
expens outsiz capital-expenditure figur news asset sale gulfport make traction asset sale announc sale marcellu
interest ohio close around formal start market water handl asset oklahoma manag also
deliv vow quickli work duc count net til plan nine turn sale gross net
turn sale despit earn miss believ share respond well asset sale news plan activ
level mesh state capital-expenditure cadenc especi given weak qtd price action qtd versu xop
sustain growth resourc optim
beat expect guid balanc lower weaker expect product encourag
commentari outperform broader market advanc previou guidanc vs prior strength activ
safeti continu believ core aptv strateg posit smart vehicl architectur simplifi vehicl design
acceler integr improv sens commun comput solut believ future-proof dynam becom
clearer custom support on-going share gain share trade lower guidanc remain construct believ
medium/long-term thesi intact lower underli market assumpt modestli lower pt result
sustain growth resourc optim
result expect maintain perform
post disappoint result part due sub-optim manag rais revenu guidanc keep ep
guidanc line compani highlight ineffici drag gm believ issu remedi
quarter note compani continu ramp seri product ahead schedul aggress book new busi
product larg book work sell product continu cautiou potenti earn upsid given
histor volatil solar price increas mix sale outsid us note execut well modul busi
soft start year guidanc maintain
adjust ep y/i estimate/consensu revenu y/i also shi
estimate/consensu respect predomin driver y/i declin adjust ep mani
softer expect includ organ revenu declin three four segment particularli commun
relat servic larg expect still y/i /weather/forex/net divestitures/on less oper day/elev oper expens
anticip recur/high interest expense/th absenc y/i gain share repurchases/an elev higher-than-expect tax rate despit
cumbersom maintain guidanc view mani issu non-recur busi transform initi
bti includ erp implement on-track anticip progress oper improv temper maintain
substanti outperform maintain guidanc
adjust ebitda grew y/i far exceed estimate/consensu respect busi
condit trend well organ revenu growth via rate optim vap expansion/penetr valu ad product servic
furnitur rental y/i acquisit integr cost synergi drove adjust ebitda margin
repres y/i improv
total revenu y/i y/i pro-forma includ modspac acton tyson acquisit period outpac
estimate/consensu respect us modular segment pro-forma rental rate growth strong y/i
repres sixth consecut quarter pro-forma double-digit rental revenu growth driven core unit rental rate growth
vap expansion/penetr us modular pro-forma unit rent decreas y/i pro-forma util tighten y/i
execut integr fleet rebalanc across branch network weather drove new order activ ramp later season
reiter total revenu adjust ebitda guidanc pro-forma y/i
pro-forma y/i respect exist estimates/consensu respect addit
reiter expect exit adjust ebitda run-rat target appear significantli closer consid
strong start year also appear meaning closer adjust ebitda estim
consid strong start anticip upbeat commentari compani confer call et
yield portfolio bit lower qoq dividend intact
banx report nie estim believ current profil portfolio like maintain yield
new invest continu come level continu model slightli increas portfolio leverag increas
end stabil although interest expens put pressur earn recent fed plot creat tailwind
continu see flat rate environ banx essenti steadyst growth preserv
capit solid dividend yield maintain price target
great busi model fundament trend easi
apo report result gener line expect nice grow base fee-rel earn fre littl
way realiz carri wait invest fund ix matur big event announc
convers corp stock react nice day suspect lot technic buy mutual
fund etf come month slide present show alt manag structur partnership
passiv ownership versu structur corp tradit asset manag
solid quarter continu impress fre growth
report solid after-tax realiz incom ri versu consensu slightli estim
earn y/i aum base manag fee better expect grab bag minor item drag earn modestli
overal top-lin growth stori continu fpaum y/i fee relat earn fre growth per share basi
call manag stress need reinvest new team drive impress growth
doubt signific factor push expens bit expect continu recommend stock point excel growth
trend outlook come year
may annual industri growth confer new yorknext tuesday wednesday
june summit emerg biotechnolog montauk ny
